Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature

详细信息    查看全文

• 作者：Jian-Xiong Li^a ; Li-Chao Fan^a ; Man-Hui Li^a ; ^b ; Wei-Jun Cao^a ; ^b ; ¹ ; Jin-Fu Xu^a ; ^b ; ¹ ; ^{jfxucn@gmail.com}
• 关键词：Allergy bronchopulmonary aspergillosis ; Aspergillus fumigates ; exacerbation ; Omalizumab ; Prednisone dosage
• 刊名：Respiratory Medicine
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：122
• 期：Complete
• 页码：33-42
• 全文大小：884 K
• 卷排序：122

文摘

The first systematic literature review of Omalizumab treatment for ABPA. Omalizumab provided a clinically important reduction in serum IgE, exacerbation rates and steroid requirement in patients with ABPA. There were no significant adverse effects reported during the study period related to Omalizumab use in ABPA patients.